Bone remodeling and hydroxyapatite resorption in coated primary hip prostheses.
Hydroxyapatite coatings for THA promote bone ongrowth, but bone and coating are exposed to stress shielding-driven osteoclastic resorption. We asked: (1) if the resorption of hydroxyapatite coating and bone ongrowth correlated with demographics; (2) if the resorption related to the stem level; and (3) what happens to the implant-bone interface when all hydroxyapatite coating is resorbed? We recovered 13 femoral components from cadaveric specimens 3.3 to 11.2 years after uneventful primary THA. Three cross sections (proximal, medial, distal) of the hydroxyapatite-coated proximal implant sleeve were analyzed by measuring the percentage of residual hydroxyapatite and bone ongrowth on the implant perimeter. Hydroxyapatite resorption was independent of patient age but increased with time in vivo and mostly was gone after 8 years. Bone ongrowth was independent of time in vivo but decreased with aging patients. Only in the most proximal section did less residual hydroxyapatite correlate with less bone ongrowth. Hydroxyapatite resorption, which was more proximal than distal, showed no adverse effects on the implant-bone interface.
Department of Orthopaedic Surgery, Atrium Medical Center, PO Box 4446, 6401, CX, Heerlen, The Netherlands.
Alphons J
AJ
Tonino
Bart C H
BC
van der Wal
Ide C
IC
Heyligers
Bernd
B
Grimm
D000368:Aged; D000369:Aged, 80 and over; D016723:Bone Remodeling; D020099:Coated Materials, Biocompatible / Q000378:metabolism*; D017886:Durapatite / Q000378:metabolism*; D005260:Female; D006622:Hip Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D015207:Osteoarthritis, Hip / Q000601:surgery
D020099:Coated Materials, Biocompatible; D017886:Durapatite